Search research articles
Contact Us
Filters
Showing results (101-110 of 217) with videos related to
Page
of 22
Sort By:
European Journal of Dermatology : EJD
|
December 15, 2012
Topical vitamin K1 may not be effective in preventing acneiform rash during cetuximab treatment in patients with metastatic colorectal cancer
Jae-Cheol Jo, Yong Sang Hong, Kyu-pyo Kim, et al.
The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi
|
February 24, 2004
[Clinical characteristics of 17 cases of autoimmune chronic pancreatitis]
Kyu-Pyo Kim, Myung- Hwan Kim, Yun Jung Lee, et al.
The Lancet. Oncology
|
October 17, 2021
Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study
Changhoon Yoo, Kyu-Pyo Kim, Jae Ho Jeong, et al.
Clinical Colorectal Cancer
|
August 6, 2018
Prognostic Value of the Microsatellite Instability Status in Patients With Stage II/III Rectal Cancer Following Upfront Surgery
Chung Ryul Oh, Jeong Eun Kim, Jihoon Kang, et al.
Cancer Research and Treatment
|
December 23, 2017
Prognosis of Pancreatic Cancer Patients with Synchronous or Metachronous Malignancies from Other Organs Is Better than Those with Pancreatic Cancer Only
Su-Jin Shin, Hosub Park, You-Na Sung, et al.
Cancer Chemotherapy and Pharmacology
|
May 22, 2013
Prospective phase II study of neoadjuvant FOLFOX6 plus cetuximab in patients with colorectal cancer and unresectable liver-only metastasis
Jun Ho Ji, Se Hoon Park, Jeeyun Lee, et al.
Anticancer Research
|
May 18, 2012
The survivin suppressant YM155 potentiates chemosensitivity to gemcitabine in the human pancreatic cancer cell line MiaPaCa-2
Dok Hyun Yoon, Jae-Sik Shin, Dong-Hoon Jin, et al.
Annals of Surgical Oncology
|
November 1, 2024
Survival Outcomes According to NCCN Criteria for Resection Following Neoadjuvant Therapy for Patients with Localized Pancreatic Cancer
Jong Keon Jang, Jae Ho Byun, Se Jin Choi, et al.
Abdominal Radiology (New York)
|
May 27, 2024
Comparison of the different versions of NCCN guidelines for predicting margin-negative resection of pancreatic cancer in patients undergoing upfront surgery
Eun Joo Park, Jong Keon Jang, Jae Ho Byun, et al.
Journal of Hepato-Biliary-Pancreatic Sciences
|
June 3, 2022
Prediction of margin-negative resection of pancreatic ductal adenocarcinoma following neoadjuvant therapy: Diagnostic performance of NCCN criteria for resection vs CT-determined resectability
Jong Keon Jang, Se Jin Choi, Jae Ho Byun, et al.
Page
of 22
Search research articles
Search
Showing results (101-110 of 217) with videos related to
Sort By:
Page
of 22
European Journal of Dermatology : EJD
|
December 15, 2012
Topical vitamin K1 may not be effective in preventing acneiform rash during cetuximab treatment in patients with metastatic colorectal cancer
Jae-Cheol Jo, Yong Sang Hong, Kyu-pyo Kim, et al.
The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi
|
February 24, 2004
[Clinical characteristics of 17 cases of autoimmune chronic pancreatitis]
Kyu-Pyo Kim, Myung- Hwan Kim, Yun Jung Lee, et al.
The Lancet. Oncology
|
October 17, 2021
Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study
Changhoon Yoo, Kyu-Pyo Kim, Jae Ho Jeong, et al.
Clinical Colorectal Cancer
|
August 6, 2018
Prognostic Value of the Microsatellite Instability Status in Patients With Stage II/III Rectal Cancer Following Upfront Surgery
Chung Ryul Oh, Jeong Eun Kim, Jihoon Kang, et al.
Cancer Research and Treatment
|
December 23, 2017
Prognosis of Pancreatic Cancer Patients with Synchronous or Metachronous Malignancies from Other Organs Is Better than Those with Pancreatic Cancer Only
Su-Jin Shin, Hosub Park, You-Na Sung, et al.
Cancer Chemotherapy and Pharmacology
|
May 22, 2013
Prospective phase II study of neoadjuvant FOLFOX6 plus cetuximab in patients with colorectal cancer and unresectable liver-only metastasis
Jun Ho Ji, Se Hoon Park, Jeeyun Lee, et al.
Anticancer Research
|
May 18, 2012
The survivin suppressant YM155 potentiates chemosensitivity to gemcitabine in the human pancreatic cancer cell line MiaPaCa-2
Dok Hyun Yoon, Jae-Sik Shin, Dong-Hoon Jin, et al.
Annals of Surgical Oncology
|
November 1, 2024
Survival Outcomes According to NCCN Criteria for Resection Following Neoadjuvant Therapy for Patients with Localized Pancreatic Cancer
Jong Keon Jang, Jae Ho Byun, Se Jin Choi, et al.
Abdominal Radiology (New York)
|
May 27, 2024
Comparison of the different versions of NCCN guidelines for predicting margin-negative resection of pancreatic cancer in patients undergoing upfront surgery
Eun Joo Park, Jong Keon Jang, Jae Ho Byun, et al.
Journal of Hepato-Biliary-Pancreatic Sciences
|
June 3, 2022
Prediction of margin-negative resection of pancreatic ductal adenocarcinoma following neoadjuvant therapy: Diagnostic performance of NCCN criteria for resection vs CT-determined resectability
Jong Keon Jang, Se Jin Choi, Jae Ho Byun, et al.
Page
of 22